Biocon Biologics to offer 15% stake to SII

Biocon Biologics Limited, a subsidiary of Biocon Ltd and Serum Institute announced a strategic alliance on Thursday and BBL said it will offer around 15 per cent stake to SILS at a post-money valuation of about USD 4.9 billion.

Leave A Reply

Your email address will not be published.